Data driven research. Our interest is to investigate underlying molecular events in tumor cohorts by integrated computational analysis of clinical and molecular data from multi-omics projects. Translate the datasets into insights that advance understanding of biomarkers/therapeutic targets and response to treatment. Current focus is to evaluate stratified patient populations for transcriptome, proteome and immune signatures in colorectal tumor with specific gene mutations.